Aine Miller - Nov 20, 2025 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
SVP, DEV & HEAD OF IRE OFFICE
Signature
/s/ Corinna Liebowitz, Attorney-in-Fact
Stock symbol
TBPH
Transactions as of
Nov 20, 2025
Transactions value $
-$125,103
Form type
4
Date filed
11/24/2025, 06:15 PM
Previous filing
Aug 22, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Miller Aine SVP, DEV & HEAD OF IRE OFFICE C/O THERAVANCE BIOPHARMA US, LLC, 901 GATEWAY BLVD, SOUTH SAN FRANCISCO /s/ Corinna Liebowitz, Attorney-in-Fact 2025-11-24 0002012524

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Tax liability -$125K -6.99K -3.36% $17.90 201K Nov 20, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.